Tag

Tepezza

All articles tagged with #tepezza

healthcare2 years ago

Amgen's Strategic Moves: From Scrapping Cancer Drug to Boosting Obesity Drug Sales

Amgen reported strong Q3 earnings and raised its full-year revenue guidance. The company completed its acquisition of Horizon Therapeutics, expanding its portfolio with drugs like Tepezza. Amgen is also venturing into the obesity drug space, with enrollment completed for its drug Mari in a phase 2 trial. The company aims to build a platform for obesity treatment and expects top-line data from the phase 2 trial by the end of 2024. Amgen is optimistic about its rare disease business and plans to expand the reach of Tepezza to more prescribers and internationally.

Amgen's $27.8B Acquisition of Horizon Therapeutics Finalized
business2 years ago

Amgen's $27.8B Acquisition of Horizon Therapeutics Finalized

Amgen has completed its $27.8 billion acquisition of Horizon Therapeutics after receiving approval from the U.S. Federal Trade Commission (FTC). As part of the settlement, Amgen is prohibited from using anti-competitive tactics to extend the market dominance of Horizon's thyroid eye disease treatment Tepezza and gout drug Krystexxa. The deal is expected to contribute to Amgen's adjusted earnings from next year, and analysts believe Tepezza could be a significant revenue driver for the company, potentially generating $3.9 billion in peak sales.